Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01038128 · ClinicalTrials.gov registry record · NA
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
A NA study, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01038128: Completed NA study, sponsored by Mclean Hospital.
NCT01038128 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01038128, a NA study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary objective of this 13-week clinical trial is to test the hypothesis that treatment with Memantine will significantly improve the symptoms of those suffering from either bulimia nervosa, purging type or suffering from body dysmorphic disorder.
Primary Outcome
Number of self-reported binge eating and self-induced vomiting episodes during the week prior to the Baseline and Endpoint Visits.
Interventions
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-05 |
| Phase | NA |
What the finished NCT01038128 record still lists
NCT01038128 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Memantine is the first listed.
NCT01038128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01038128 about?
NCT01038128 is a clinical study titled "An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder". The primary objective of this 13-week clinical trial is to test the hypothesis that treatment with Memantine will significantly improve the symptoms of those suffering from either bulimia nervosa, purging type or suffering from body dysmorphic disorder.
What is the current status of trial NCT01038128?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-12. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01038128?
The interventions under investigation include: Memantine (DRUG).
Who is sponsoring clinical trial NCT01038128?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01038128's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia